Global Renal Biomarker Market By Biomarker Type (Functional Biomarkers (Serum Creatinine, Blood Urea Nitrogen (BUN) and Estimated Glomerular Filtration Rate (eGFR)), Upregulated Proteins (Neutrophil Gelatinase-Associated Lipocalin (NGAL), Kidney Injury Molecule-1 (KIM-1), Cystatin C, Interleukin-18 (IL-18) and Others) and Others), By Technique (Immunoassays, Mass Spectrometry, Point-of-Care Tests, Enzyme-Linked Immunosorbent Assay (ELISA), Molecular Diagnostics and Others), By End-User (Hospitals, Diagnostic Laboratories, Academic & Research Institutes and Others), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034
- Published date: Jan 2026
- Report ID: 173054
- Number of Pages: 208
- Format:
-
keyboard_arrow_up
-
-
- BioMerieux SA
- Siemens Healthineers AG
- Thermo Fisher Scientific Inc.
- BioPorto Diagnostics A/S
- SEKISUI Medical Co., Ltd.
- Danaher
- Randox Laboratories Ltd
- QIAGEN N.V.
- DiaSorin S.p.A.
- Becton, Dickinson & Co.
- Bio-Rad Laboratories Inc.
- SphingoTec GmbH
- EKF Diagnostics Holdings plc.
- Abbott Laboratories
- Nordic Bioscience
Our Clients
Kickstart 2026 with Exclusive Savings
✖
Request a Sample Report
We'll get back to you as quickly as possible